GlassScriptPhysician profile
Bertilia M Toca
NPI 1457339582
$10,012.92
in general payments reported to CMS, 2019-2025
16 companies · $2,821 in 2025
The $2,821 reported for 2025 was more than what 92% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,196 · 2020: $469 · 2021: $838 · 2022: $1,142 · 2023: $1,745 · 2024: $1,802 · 2025: $2,821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,253 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,252.88 |
| Education | $115.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $1,808.68 | 2019-2025 | Aristada, Lybalvi, Aristada Initio |
| Otsuka America Pharmaceutical, INC. | $1,495.25 | 2019-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Sunovion Pharmaceuticals INC. | $1,006.77 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $972.62 | 2019-2025 | Invega Sustenna, Invega Trinza, Spravato |
| Teva Pharmaceuticals USA, INC. | $957.79 | 2019-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Vanda Pharmaceuticals INC. | $753.45 | 2021-2025 | Fanapt, Hetlioz |
| Axsome Therapeutics, INC. | $615.29 | 2023-2025 | Auvelity |
| Abbvie INC. | $609.86 | 2021-2025 | Vraylar |
| Lundbeck LLC | $574.94 | 2019-2025 | Abilify Maintena, Rexulti |
| E.R. Squibb & Sons, L.L.C. | $362.84 | 2025 | Cobenfy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $357.83 | 2021-2025 | Caplyta |
| Neurocrine Biosciences, INC. | $294.47 | 2019-2025 | Ingrezza |
| Indivior INC. | $72.85 | 2022-2024 | Perseris |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $72.04 | 2023 | |
| Allergan, INC. | $39.81 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $18.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bertilia Toca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.